OOIR: Observatory of International Research

Papers

(The H4-Index of Applied Microbiology and Biotechnology is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Microplastics provide new microbial niches in aquatic environments	212
Detection technologies and recent developments in the diagnosis of COVID-19 infection	197
The microbial coinfection in COVID-19	193
Crosstalk between ER stress, NLRP3 inflammasome, and inflammation	137
Industrial biotechnology of Pseudomonas putida: advances and prospects	127
Role of probiotics to combat viral infections with emphasis on COVID-19	117
Recent advances and new strategies on leishmaniasis treatment	106
Application of artificial intelligence models and optimization algorithms in plant cell and tissue culture	102
Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis	96
Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics	92
The potential of Akkermansia muciniphila in inflammatory bowel disease	89
Microbial astaxanthin biosynthesis: recent achievements, challenges, and commercialization outlook	89
Indole-3-acetic acid biosynthesis and its regulation in plant-associated bacteria	86
Biotechnology of Rhodococcus for the production of valuable compounds	85
Several ways one goal—methanogenesis from unconventional substrates	81
Novel unexpected functions of PHA granules	81
Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation	74
Auxins of microbial origin and their use in agriculture	73
Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook	73
A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress–induced depressive-like behavior in mice by regulating gut microbiota and metabolites	67
Bacillus as a source of phytohormones for use in agriculture	64
Fungal bioremediation of soil co-contaminated with petroleum hydrocarbons and toxic metals	63
The role of microorganisms on biotransformation of brewers’ spent grain	60
Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites	60
Health benefits of xylitol	59

Iron and zinc ions, potent weapons against multidrug-resistant bacteria	59
Current advances on waste biomass transformation into value-added products	58
Green synthesis of multipurpose carbon quantum dots from red cabbage and estimation of their antioxidant potential and bio-labeling activity	57
Biogenesis of silver nanoparticles to treat cancer, diabetes, and microbial infections: a mechanistic overview	55
Transaminases for industrial biocatalysis: novel enzyme discovery	55
Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets	54
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story	53
(Bio)Technological aspects of microalgae pigments for cosmetics	53
Advances on the in vivo and in vitro glycosylations of flavonoids	53
Unraveling microbial fermentation features in kimchi: from classical to meta-omics approaches	51
Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials	50
Engineering intracellular malonyl-CoA availability in microbial hosts and its impact on polyketide and fatty acid synthesis	50
Echinocandins: structural diversity, biosynthesis, and development of antimycotics	49
Metabolic engineering and synthetic biology for isoprenoid production in Escherichia coli and Saccharomyces cerevisiae	49
Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections	48
Progress in bioleaching: part B, applications of microbial processes by the minerals industries	48
Motility of Vibrio spp.: regulation and controlling strategies	48
Current status on the biodegradability of acrylic polymers: microorganisms, enzymes and metabolic pathways involved	47
Lipid metabolism of the oleaginous yeast Lipomyces starkeyi	47
Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation	47
Campylobacter sp.: Pathogenicity factors and prevention methods—new molecular targets for innovative antivirulence drugs?	47
Catalytically-active inclusion bodies for biotechnology—general concepts, optimization, and application	47